Natco Pharma LtdPharmaceuticalsINE987B01026Consolidated₹813.40-4.85 (-0.59%)Jun-26
Valuation
Market Cap₹14.57K Cr
TTM PE12.73x
Forward PE17.45x
PEG-0.66
Book Value₹514.83
P/B1.58x
TTM EPS₹63.89
Fwd EPS₹46.60
TTM Revenue₹3.48K Cr
TTM PAT₹1.14K Cr
TTM EBITDA₹1.05K Cr
TTM EBIT₹855.90 Cr
Last Qtr PAT₹206.50 Cr
Last Qtr EBITDA₹186.50 Cr
Last Qtr EBIT₹139.40 Cr
Profitability
ROE12.41%
ROCE11.59%
TTM NPM32.85%
TTM EBITDA %30.19%
Curr OPM25.99%
Last OPM32.93%
Curr NPM—
Last NPM—
Curr EPS₹11.53
Last EPS₹14.96
Balance sheet
Equity₹35.80 Cr
Reserve₹9.19K Cr
Total Debt₹713.90 Cr
D/E0.08x
Interest %6.30%
Curr Interest₹13.00 Cr
Price / range
Close₹813.40
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D-0.59%
1W-0.24%
1M-9.46%
3M-7.93%
6M-15.05%
1Y-8.02%
2Y-47.19%
3Y-6.31%
5Y-13.23%
Diwali-8.46%
Sector peers — Pharmaceuticals
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits